Xiangyu Chu

1.1k total citations · 2 hit papers
32 papers, 783 citations indexed

About

Xiangyu Chu is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Xiangyu Chu has authored 32 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Rheumatology and 8 papers in Cancer Research. Recurrent topics in Xiangyu Chu's work include Osteoarthritis Treatment and Mechanisms (8 papers), Wound Healing and Treatments (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Xiangyu Chu is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Wound Healing and Treatments (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Xiangyu Chu collaborates with scholars based in China, United States and Germany. Xiangyu Chu's co-authors include Hongbo You, Xiaojian Huang, Bowei Ni, Xi Yang, Guohui Liu, Yuan Xiong, Bobin Mi, Ze Lin, Adriana C. Panayi and Kangkang Zha and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

In The Last Decade

Xiangyu Chu

32 papers receiving 771 citations

Hit Papers

Reactive Oxygen Species‐Scavenging Nanosystems in the Tre... 2023 2026 2024 2025 2023 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyu Chu China 16 305 166 137 130 105 32 783
Xin Pan China 16 411 1.3× 56 0.3× 70 0.5× 131 1.0× 92 0.9× 24 844
Huarong Shao China 16 189 0.6× 82 0.5× 172 1.3× 69 0.5× 115 1.1× 36 696
Mi Ran Byun South Korea 17 540 1.8× 76 0.5× 46 0.3× 112 0.9× 42 0.4× 33 1.1k
Ki‐Sook Park South Korea 22 648 2.1× 103 0.6× 47 0.3× 62 0.5× 77 0.7× 64 1.3k
Tae‐Rin Kwon South Korea 20 317 1.0× 81 0.5× 33 0.2× 73 0.6× 67 0.6× 73 1.2k
Young‐Ae Choi South Korea 19 479 1.6× 38 0.2× 192 1.4× 150 1.2× 74 0.7× 59 1.3k
Patrick Bogdanowicz France 16 260 0.9× 73 0.4× 355 2.6× 46 0.4× 61 0.6× 28 965
Dasheng Lin China 21 327 1.1× 54 0.3× 91 0.7× 101 0.8× 76 0.7× 68 1.3k
Yung‐Hsin Cheng Taiwan 17 241 0.8× 55 0.3× 43 0.3× 99 0.8× 184 1.8× 22 959

Countries citing papers authored by Xiangyu Chu

Since Specialization
Citations

This map shows the geographic impact of Xiangyu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Chu more than expected).

Fields of papers citing papers by Xiangyu Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Chu. The network helps show where Xiangyu Chu may publish in the future.

Co-authorship network of co-authors of Xiangyu Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Chu. A scholar is included among the top collaborators of Xiangyu Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Chu. Xiangyu Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dongqi, Xiangyu Chu, Yinmo Yang, et al.. (2025). The functional extracellular vesicles target tumor microenvironment for gastrointestinal malignancies therapy. SHILAP Revista de lepidopterología. 5. 100077–100077. 1 indexed citations
2.
Xiong, Yuan, Ze Lin, Xiangyu Chu, et al.. (2024). Novel cocktail therapy based on multifunctional supramolecular hydrogel targeting immune-angiogenesis-nerve network for enhanced diabetic wound healing. Journal of Nanobiotechnology. 22(1). 749–749. 6 indexed citations
3.
Li, Dongqi, Xiangyu Chu, Yongsu Ma, et al.. (2024). Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation. Cancer Letters. 611. 217403–217403. 6 indexed citations
4.
Lü, Li, Xiangyu Chu, Yuan Xiong, et al.. (2024). Cell membrane coated nanoparticles: cutting-edge drug delivery systems for osteoporosis therapy. Nanoscale. 16(17). 8236–8255. 5 indexed citations
5.
Lv, Bin, Ze Lin, Xiangyu Chu, et al.. (2024). Neddylation suppression by a macrophage membrane-coated nanoparticle promotes dual immunomodulatory repair of diabetic wounds. Bioactive Materials. 34. 366–380. 26 indexed citations
6.
Chu, Xiangyu, Bobin Mi, Yuan Xiong, et al.. (2024). Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment. Biomaterials. 312. 122714–122714. 13 indexed citations
7.
Li, Dongqi, et al.. (2024). The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies. RNA Biology. 22(1). 1–14. 1 indexed citations
8.
Xiong, Yuan, Xiangyu Chu, Tao Yu, et al.. (2023). Reactive Oxygen Species‐Scavenging Nanosystems in the Treatment of Diabetic Wounds. Advanced Healthcare Materials. 12(25). e2300779–e2300779. 123 indexed citations breakdown →
9.
Xiong, Yuan, Qian Feng, Li Lü, et al.. (2023). Immunomodulatory Hydrogels: Advanced Regenerative Tools for Diabetic Foot Ulcer. Advanced Functional Materials. 33(10). 96 indexed citations breakdown →
10.
Wang, Ding, et al.. (2022). Through network pharmacology and molecular docking to explore the underlying mechanism of Artemisia annua L. treating in abdominal aortic aneurysm. Frontiers in Physiology. 13. 1034014–1034014. 4 indexed citations
11.
12.
Lü, Li, Yuan Xiong, Ze Lin, et al.. (2022). Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders. Frontiers in Pharmacology. 13. 1009550–1009550. 18 indexed citations
13.
Chu, Xiangyu, Biao Kuang, Yiqing Wang, et al.. (2021). Combined gene therapy via VEGF and mini-dystrophin synergistically improves pathologies in temporalis muscle of dystrophin/utrophin double knockout mice. Human Molecular Genetics. 30(14). 1349–1359. 9 indexed citations
14.
Ni, Bowei, Rui Zhang, Xiangyu Chu, et al.. (2021). MCC950, the NLRP3 Inhibitor, Protects against Cartilage Degradation in a Mouse Model of Osteoarthritis. Oxidative Medicine and Cellular Longevity. 2021(1). 4139048–4139048. 43 indexed citations
15.
Liu, Xinxin, et al.. (2021). Prophylactic Intra-Peritoneal Drainage After Pancreatic Resection: An Updated Meta-Analysis. Frontiers in Oncology. 11. 658829–658829. 13 indexed citations
16.
17.
Huang, Xiaojian, Xi Yang, Bowei Ni, et al.. (2019). p-Coumaric Acid Attenuates IL-1β-Induced Inflammatory Responses and Cellular Senescence in Rat Chondrocytes. Inflammation. 43(2). 619–628. 42 indexed citations
18.
Huang, Xiaojian, Bowei Ni, Zekai Mao, et al.. (2019). NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway. Journal of Cellular and Molecular Medicine. 23(11). 7525–7534. 40 indexed citations
19.
Huang, Xiaojian, Xi Yang, Zekai Mao, et al.. (2019). Vanillic acid attenuates cartilage degeneration by regulating the MAPK and PI3K/AKT/NF-κB pathways. European Journal of Pharmacology. 859. 172481–172481. 58 indexed citations
20.
Chu, Xiangyu, et al.. (2013). Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis. International Journal of Molecular Medicine. 31(5). 1222–1228. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026